Versuchen GOLD - Frei

'We're now in the era of speed of doing business'

Business Standard

|

November 13, 2024

The Andhra Pradesh government on Tuesday signed a memorandum of understanding (MoU) with Reliance Industries under which the conglomerate will invest ₹65,000 crore to set up 500 compressed biogas plants in the state in five years.

'We're now in the era of speed of doing business'

NARA LOKESH, who led negotiations, tells Archis Mohan in an interview over telephone and email that the government moved from proposal to MoU in just 30 days, underscoring its conviction that the "era of 'ease of doing business' is over".

Popular in Andhra Pradesh as the "job creator in chief", the state minister of IT, electronics & communications, and human resource development, says the mantra now is "speed of doing business".

Edited excerpts:

What are the expectations for Reliance's investment in compressed biogas (CBG) plants in Andhra Pradesh (AP), and how does this align with your broader vision of positioning the state as a clean energy hub?

Additionally, how was the RIL investment negotiated and finalised in 30 days? Over the past five years, we had a deeply anti-business government. Rather than encouraging businesses, it created an environment of extortion and fear that stifled expansion. Several businesses left AP for neighbouring states.

Reliance is among India's most valuable corporations with the finest track record of execution of projects at scale. They have been partners to AP over the past two-three decades across businesses spanning oil & gas, retail, and telecom. However, even their investments tapered in AP over the past few years. This investment commitment by RIL is extremely significant for us, because it reinforces a message: AP is open for business again. It is a matter of pride that we were able to move from proposal to MoU in 30 days, besides developing a favourable policy for the bio-fuel sector in the interim.

WEITERE GESCHICHTEN VON Business Standard

Business Standard

Labour Codes impact: HCL tech profit slips 11%

Q3 top line beats Street estimates, bottom line misses expectations

time to read

2 mins

January 13, 2026

Business Standard

New labour Codes, restructuring weigh on TCS earnings

Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Black drives the thrill for car buyers

Sees a surge in yearly sales, while white remains practical 'utility king'

time to read

2 mins

January 13, 2026

Business Standard

CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS

Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be

time to read

2 mins

January 13, 2026

Business Standard

Business Standard

China’s PVC rethink to help India pipe makers

Supply likely to tighten after S-PVC rebate withdrawal

time to read

2 mins

January 13, 2026

Business Standard

Responsible growth

India must ensure data centres are sustainable

time to read

2 mins

January 13, 2026

Business Standard

India’s GenZ is full of creativity: PM

Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Iran wants to negotiate after threats to attack, says Trump

At least 572 killed in protests; Tehran says situation ‘under full control’

time to read

2 mins

January 13, 2026

Business Standard

Insurers knock on Irdai door for clarity on director overlap ban

CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY

time to read

2 mins

January 13, 2026

Business Standard

Delhi HC allows Zydus to sell generic version of cancer drug

Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.

time to read

1 min

January 13, 2026

Listen

Translate

Share

-
+

Change font size